Dalian BIO-CHEM Company Limited
603360.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.47B
Close$
$21.26
75.3% upside
Current Fair Value
75.3% upsideUndervalued by 75.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.47 Billion |
|---|---|
| Enterprise Value | $9.06 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.3 |
| Beta | 0.14 |
| Outstanding Shares | 689,276,138 |
Return
| Return on Equity | 12.09% |
|---|---|
| Return on Assets | 4.37% |
| Return on Invested Capital | 10.23% |
Valuation & Multiples
| P/E Ratio | 46.55 |
|---|---|
| PEG | -259.26 |
| Price to Sales | 6.07 |
| Price to Book Ratio | 6.07 |
| Enterprise Value to Revenue | 5.82 |
| Enterprise Value to EBIT | 29.91 |
| Enterprise Value to Net Income | 53 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 1.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Dalian BIO-CHEM Company Limited
1,053 employees
CEO: Hailong Liu Established in 2003 and headquartered in Dalian, China, Dalian BIO-CHEM Company Limited specializes in the manufacture and distribution of antimicrobial agents, specifically bactericides, antiseptics, and fungicides. These products serve...